Prasugrel Tablet, Film Coated
Product Images NDC 16729-273

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Prasugrel (NDC 16729-273). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Prasugrel Tablets 10 mg 30 Tablets (Container Label)

Prasugrel Tablets 10 mg 30 Tablets (Container Label)
This is a medication information label for Prasugrel tablets. Each film-coated tablet contains Prasugrel Hydrochloride, which is equivalent to 10 mg of Prasugrel. The usual dosage instructions can be found in the accompanying package insert. The tablets should be kept out of reach of children and stored at a temperature between 20°C to 25°C (68°F to 77°F), as per USP Controlled Room Temperature specifications. The tablets are manufactured by Intas Pharmaceuticals Limited, located in Ahmedabad, India, for Accord Healthcare Inc., based in Durham, NC. The medication is available in 30 tablets per container, and the pharmacist should dispense the enclosed Medication Guide to each patient. It also includes Lot and EXP & Data matrix specifications.*
FDA Label Image

Prasugrel Tablets 5 mg 30 Tablets-container Label (Prasugrel 5mg 30 Label)

Prasugrel Tablets 5 mg 30 Tablets-container Label (Prasugrel 5mg 30 Label)
Each film-coated tablet contains Prasugrel Hydrochioride, equivalent to Prasugrel 5 mg. The usual dosage should be checked on the accompanying package insert. The tablets should be kept out of reach of children and stored in the original container, between 20°C to 25°C. The product is manufactured by Intas Pharmaceuticals Limited in India, and distributed by Accord Healthcare Inc. in Durham, NC, with an NDC of 16729-272-10. The enclosed medication guide should be dispensed to each patient by the pharmacist. The text includes additional information for handling and storing the product.*
FDA Label Image

Figure 1 (Prasugrel Fig1)

Figure 1 (Prasugrel Fig1)
This appears to be a chart or table related to the drug Prasugrel and bleeding events. It shows the percentage of major or minor bleeding events related to Non-CABG (Coronary Artery Bypass Grafting) patients. It also provides some numbers related to Bays/ram Randomization. Without additional context, it's difficult to provide more information.*
FDA Label Image

Figure 2 (Prasugrel Fig2)

FDA Label Image

Figure 3 (Prasugrel Fig3)

Figure 3 (Prasugrel Fig3)
This appears to be a graph showing the percentage of cardiovascular deaths, nonfatal myocardial infarctions, or nonfatal strokes among patients with UA/NSTEMI treated with either clopidogrel or prasugrel over the course of several months. The x-axis measures the number of days from randomization while the y-axis shows the percentage of patients experiencing these events.*
FDA Label Image

Figure 3 (Prasugrel Fig4)

Figure 3 (Prasugrel Fig4)
This is a graph that shows the incidence rate of cardiovascular death, nonfatal MI, or nonfatal stroke (%), over time (days) from randomization for two treatments: Clopidogrel and Prasugrel. The y-axis shows the percentage of patients who experienced cardiovascular death, nonfatal MI, or nonfatal stroke, while the x-axis shows the number of days from randomization. There does not seem to be any text available to provide more context to the graph.*
FDA Label Image

Figure 4 (Prasugrel Fig5)

Figure 4 (Prasugrel Fig5)
This text provides baseline characteristics for a study, possibly related to medical procedures or treatments. It includes information about age, weight, medical history, geographic location, and medication use. The table at the end shows the percentage of events for two medications, Prasugrel and Clopidogrel, with a comparison of their effectiveness.*
FDA Label Image

Figure 5 (Prasugrel Fig6)

Figure 5 (Prasugrel Fig6)
This text seems to be a data table with various headings like Gender, Body Weight, Region, etc and their corresponding values. It also includes some medical terms like Disbetes litus, MesaboicSyndrome, and Previous Ml which might be related to a medical study. The last two columns seem to show the percent events and hazard ratio for two types of drugs, Clopidogrel and Prasugrel, with the respective values. Overall, this seems to be a research dataset related to some kind of medical study, but it is not clear what kind of study it represents.*
FDA Label Image

Structural Formula (Prasugrel Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.